← Back
Data updated: Mar 10, 2026
FERNDALE LABS
Pharmaceuticals
FERNDALE LABS is a generic drug manufacturer with 13 FDA-approved products.
1973
Since
13
Drugs
-
Trials
18
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DIAZEPAM 2025-11-14
DIAZEPAM 2025-08-08
Labeling
DIAZEPAM 2025-08-08
Labeling
DIAZEPAM 2025-08-08
Labeling
DIAZEPAM 2025-06-13
Labeling
DIAZEPAM 2025-06-13
Labeling
DIAZEPAM 2025-05-19
DIAZEPAM 2024-12-31
DIAZEPAM 2024-12-17
Labeling
DIAZEPAM 2024-12-16
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (11)
Company Info
- First Approval
- 1973-11-13
- Latest
- 1991-11-20
- Applications
- 15